Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung

BACKGROUND: The histological classification of non-small cell lung cancer (NSCLC) is essential in determining new cancer-specific targeted therapies. However, the accurate typing of poorly differentiated is difficult, particularly for poorly differentiated squamous cell carcinoma and adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kai, Yuichiro, Amatya, Vishwa Jeet, Kushitani, Kei, Kambara, Takahiro, Suzuki, Rui, Fujii, Yutaro, Tsutani, Yasuhiro, Miyata, Yoshihiro, Okada, Morihito, Takeshima, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947391/
https://www.ncbi.nlm.nih.gov/pubmed/33718020
http://dx.doi.org/10.21037/tlcr-20-857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947391/
https://www.ncbi.nlm.nih.gov/pubmed/33718020
http://dx.doi.org/10.21037/tlcr-20-857

Ejemplares similares